United Therapeutics profit soars

United Therapeutics, of Silver Spring, a biotechnology company, nearly doubled its profit for 2014, boosted by a strong fourth quarter. United Therapeutics reported net income of $340.1 million, or $6.28 per diluted share, for the year, compared with $174.6 million and $3.28 for 2013. In the quarter ended Dec. 31, the firm posted net income ...

Leave a Reply

Your email address will not be published. Required fields are marked *